Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial function in schimke-immunoosseous dysplasia.

Thomas Lücke1, Jochen H H Ehrich, Anibh M Das

  • 1Department of Pediatrics, Hannover Medical School, Hannover, Germany. luecke.thomas@mh-hannover.de

Metabolic Brain Disease
|September 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in breastfeeding support in maternity hospitals due to the COVID-19 pandemic from the perspective of healthcare professionals in Germany.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

LMS-based continuous reference values for the myokine musclin in serum in children and adults.

Frontiers in endocrinology·2026
Same author

Additional Costs of Diets for Metabolic Diseases in Children and Adolescents: Exemplary Scenario Calculations in Germany.

Klinische Padiatrie·2026
Same author

Progressive short stature in Pearson syndrome and the impact of organ failure.

Molecular genetics and metabolism·2026
Same author

Kidney Injury Urine Biomarker Normal Ranges in Children.

Kidney international reports·2026
Same author

[Psychosomatics in children with severe neurogenetic and complex neurological diseases].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson's disease.

Metabolic brain disease·2026
Same journal

Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.

Metabolic brain disease·2026
Same journal

Sex-specific gut microbiota and metabolite signatures in Parkinson's disease: implications for personalized therapeutics.

Metabolic brain disease·2026
Same journal

Genetic mutations and synaptic dysfunctions in social interaction disorders: insights from invertebrate models to humans.

Metabolic brain disease·2026
Same journal

Crocin alleviates "short-term" Cadmium-induced brain and lung toxicities: investigation of key neuropeptides GLP-1 and spexin as biomarkers.

Metabolic brain disease·2026
Same journal

Electroacupuncture-modulated DHCR24 facilitates spinal cord injury recovery by attenuating apoptosis and neuroinflammation via the Wnt signaling pathway.

Metabolic brain disease·2026
See all related articles

Schimke-immunoosseous dysplasia (SIOD) is a rare genetic disorder. This study found no evidence of mitochondrial dysfunction in SIOD patients, leaving its cause unknown.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pathophysiology

Background:

  • Schimke-immunoosseous dysplasia (SIOD) is a severe multisystemic disorder.
  • Key features include skeletal dysplasia, nephrotic syndrome, immune deficiency, and ischemic attacks.
  • The exact pathophysiological mechanism of SIOD remains unclear.

Purpose of the Study:

  • To investigate the potential role of mitochondrial dysfunction in the pathophysiology of SIOD.
  • To test the hypothesis that impaired mitochondrial function contributes to SIOD's multisystemic manifestations.

Main Methods:

  • Analyzed blood and urine metabolites (lactate, pyruvate, ketone bodies, alanine, organic acids) in four SIOD patients.
  • Assessed respiratory chain enzyme activities (I-V) in fibroblast cultures from two SIOD patients.

Related Experiment Videos

Main Results:

  • Patients with severe SIOD exhibited normal plasma lactate, lactate/pyruvate ratios, and ketone body concentrations.
  • Alanine levels, a long-term indicator of lactate, were also normal.
  • No significant reduction in respiratory chain enzyme activities was observed in patient fibroblasts.

Conclusions:

  • The study found no evidence to support mitochondrial dysfunction as an underlying mechanism in SIOD.
  • The pathophysiology of Schimke-immunoosseous dysplasia remains to be elucidated.